Published in Cell Stem Cell on March 06, 2009
Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell (2012) 3.33
Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet (2010) 3.26
Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 3.02
Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol Med (2010) 2.86
Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol (2009) 2.37
Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol (2012) 2.36
Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther (2010) 2.29
Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng (2012) 2.27
Immunobiology of mesenchymal stem cells. Cell Death Differ (2013) 2.18
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy. Proc Natl Acad Sci U S A (2012) 2.13
Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin (2013) 2.10
Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci (2009) 1.79
Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res (2010) 1.73
Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med (2011) 1.72
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev (2013) 1.52
Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model. Clin Cancer Res (2009) 1.48
Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells (2012) 1.46
Exosomes derived from mesenchymal stem cells. Int J Mol Sci (2014) 1.43
Engineered cell homing. Blood (2011) 1.43
Human cerebrospinal fluid regulates proliferation and migration of stem cells through insulin-like growth factor-1. Stem Cells Dev (2015) 1.42
Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int (2012) 1.41
Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med (2011) 1.31
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation. Stem Cells Int (2013) 1.30
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. World J Stem Cells (2014) 1.29
Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther (2010) 1.28
Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res Ther (2010) 1.28
Cell-surface sensors for real-time probing of cellular environments. Nat Nanotechnol (2011) 1.28
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev (2010) 1.25
Stem cell homing in musculoskeletal injury. Biomaterials (2010) 1.23
Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis. Biomed Res Int (2013) 1.19
Stem cells in the face: tooth regeneration and beyond. Cell Stem Cell (2012) 1.18
Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton. J Cell Biochem (2010) 1.16
The immunomodulatory properties of mesenchymal stem cells. Semin Immunopathol (2011) 1.16
Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One (2012) 1.14
Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells. Stem Cells Transl Med (2012) 1.14
Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms. Stem Cells (2012) 1.14
Stem cells as vectors for antitumour therapy. Thorax (2010) 1.14
Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells. Proc Natl Acad Sci U S A (2011) 1.14
Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting. Biomaterials (2010) 1.13
Guided migration of neural stem cells derived from human embryonic stem cells by an electric field. Stem Cells (2012) 1.11
Identification of barriers to retinal engraftment of transplanted stem cells. Invest Ophthalmol Vis Sci (2009) 1.10
Cell sources for bone tissue engineering: insights from basic science. Tissue Eng Part B Rev (2011) 1.10
mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. Blood (2013) 1.09
Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy. World J Stem Cells (2010) 1.09
Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity. Diabetes (2012) 1.08
Cellular and extracellular programming of cell fate through engineered intracrine-, paracrine-, and endocrine-like mechanisms. Biomaterials (2011) 1.08
The mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanisms. Neuropsychopharmacology (2010) 1.07
To grab the stroma by the horns: from biology to cancer therapy with mesenchymal stem cells. Oncotarget (2013) 1.05
Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth. J Bone Miner Res (2012) 1.03
Mesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: effects of chemokines and shear. PLoS One (2011) 1.02
Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lung. Stem Cells Dev (2011) 1.02
miR-146a-5p circuitry uncouples cell proliferation and migration, but not differentiation, in human mesenchymal stem cells. Nucleic Acids Res (2013) 1.02
Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications. Mol Ther (2015) 1.02
Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease. Clin Exp Immunol (2010) 1.00
Enhanced homing permeability and retention of bone marrow stromal cells by noninvasive pulsed focused ultrasound. Stem Cells (2012) 1.00
The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration. Cytotherapy (2015) 1.00
From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? Stem Cells Int (2013) 0.99
Clinical applications of mesenchymal stem cells in chronic diseases. Stem Cells Int (2014) 0.98
Mesenchymal stromal cells for cardiovascular disease. J Cardiovasc Dis Res (2011) 0.98
Quantitative Magnetic Particle Imaging Monitors the Transplantation, Biodistribution, and Clearance of Stem Cells In Vivo. Theranostics (2016) 0.98
Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study. Stem Cells Int (2011) 0.97
The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms. Stem Cell Res Ther (2012) 0.97
Inflammation in intervertebral disc degeneration and regeneration. J R Soc Interface (2015) 0.97
Gene-modified mesenchymal stem cells protect against radiation-induced lung injury. Mol Ther (2012) 0.97
Human umbilical cord mesenchymal stem cells transplantation promotes cutaneous wound healing of severe burned rats. PLoS One (2014) 0.96
Amputation induces stem cell mobilization to sites of injury during planarian regeneration. Development (2012) 0.96
Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways. Breast Cancer Res (2013) 0.96
Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy. Pediatr Surg Int (2010) 0.96
Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials. Nano Today (2011) 0.96
Resveratrol inhibits ionising irradiation-induced inflammation in MSCs by activating SIRT1 and limiting NLRP-3 inflammasome activation. Int J Mol Sci (2013) 0.95
Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model. Neoplasia (2011) 0.95
Functional tooth restoration by allogeneic mesenchymal stem cell-based bio-root regeneration in swine. Stem Cells Dev (2013) 0.95
The dual effect of mesenchymal stem cells on tumour growth and tumour angiogenesis. Stem Cell Res Ther (2013) 0.95
Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes. Stem Cells Transl Med (2012) 0.94
Delivery of platelet-derived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds. PLoS One (2012) 0.94
Renal capsule as a stem cell niche. Am J Physiol Renal Physiol (2010) 0.93
Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal. Proc Natl Acad Sci U S A (2014) 0.92
Modulation of stromal cell-derived factor-1/CXC chemokine receptor 4 axis enhances rhBMP-2-induced ectopic bone formation. Tissue Eng Part A (2012) 0.91
The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth. Cell Biosci (2012) 0.91
Intrathecal bone marrow stromal cells inhibit neuropathic pain via TGF-β secretion. J Clin Invest (2015) 0.90
Tanshinone IIA and astragaloside IV promote the migration of mesenchymal stem cells by up-regulation of CXCR4. Protoplasma (2012) 0.90
miR-125b Is an adhesion-regulated microRNA that protects mesenchymal stem cells from anoikis. Stem Cells (2012) 0.90
A small-molecule screen for enhanced homing of systemically infused cells. Cell Rep (2015) 0.90
Animal models for vascular tissue-engineering. Curr Opin Biotechnol (2013) 0.89
Stem cell membrane engineering for cell rolling using peptide conjugation and tuning of cell-selectin interaction kinetics. Biomaterials (2012) 0.89
Investigation of cellular and molecular responses to pulsed focused ultrasound in a mouse model. PLoS One (2011) 0.88
Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma. Thorax (2014) 0.88
Mimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions. FASEB J (2011) 0.88
An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis. PLoS One (2014) 0.88
A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging. PLoS One (2014) 0.88
Migration and proliferation of human mesenchymal stem cells is stimulated by different regions of the mechano-growth factor prohormone. J Mol Cell Cardiol (2010) 0.88
Current perspectives in mesenchymal stem cell therapies for osteoarthritis. Stem Cells Int (2014) 0.88
Strategies to Optimize Adult Stem Cell Therapy for Tissue Regeneration. Int J Mol Sci (2016) 0.87
A chemically-defined screening platform reveals behavioral similarities between primary human mesenchymal stem cells and endothelial cells. Integr Biol (Camb) (2012) 0.87
Systematic analysis of in vitro cell rolling using a multi-well plate microfluidic system. J Vis Exp (2013) 0.87
Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors. Mol Cancer (2011) 0.87
In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment. Tissue Eng Part B Rev (2013) 0.87
Immunological properties of embryonic and adult stem cells. World J Stem Cells (2010) 0.87